Spectral AI, Inc. (NASDAQ:MDAI ) Q2 2025 Earnings Conference Call August 12, 2025 5:00 PM ET Company Participants Dr.Michael DiMaio - Chairman of the Board Sara Prendergast - Corporate Participant Assistant General Counsel - Corporate Participant Vincent Stanley Capone - CFO, General Counsel & Corporate Secretary Conference Call Participants Carl Edward Byrnes - Northland Capital Markets, Research Division John D. Vandermosten - Zacks Small-Cap Research Ryan Benjamin Zimmerman - BTIG, LLC, Research Division Operator Good afternoon, everyone, and welcome to the Spectral AI Inc. Q2 2025 Financial Results Conference Call.
Spectral AI, Inc. (NASDAQ:MDAI ) Q1 2025 Earnings Conference Call May 13, 2025 5:00 PM ET Company Participants Sara Prendergast - Assistant General Counsel Vincent Capone - CFO Conference Call Participants Ryan Zimmerman - BTIG Carl Byrnes - Northland Capital Markets John Vandermosten - Zacks Vadim Khalil - SP Angel Operator Good day, and welcome to the Spectral AI, Inc. First Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note that this event is being recorded.
Spectral AI, Inc. (NASDAQ:MDAI ) Q4 2024 Earnings Conference Call March 27, 2025 5:00 PM ET Company Participants Sara Prendergast - Assistant General Counsel Michael DiMaio - Chairman Vincent Capone - CFO Jihang Wang - Director of Data Science at Spectral AI Conference Call Participants Carl Byrnes - Northland Capital Markets Ryan Zimmerman - BTIG John Vandermosten - Zacks RK Ramakanth - H.C. Wainwright Operator Good afternoon, and welcome to the Spectral AI Fourth Quarter and Full Year 2024 Financial Results Conference Call.
| Health Care Technology Industry | Healthcare Sector | Wensheng Fan CEO | NASDAQ (CM) Exchange | 84757T105 CUSIP |
| US Country | 78 Employees | - Last Dividend | - Last Split | 6 Apr 2021 IPO Date |
Spectral AI, Inc. is at the forefront of artificial intelligence (AI) innovation, specializing in the field of medical diagnostics. Based in Dallas, Texas, the company's mission focuses on enhancing the speed and accuracy of treatment decisions for patients suffering from burns, diabetic foot ulcers, and similar complex wounds. By integrating AI into the process of medical diagnostics, Spectral AI, Inc. aims to revolutionize the way clinicians assess and approach wound care, ultimately contributing to more effective patient outcomes and the advancement of healthcare technology.
A cornerstone product of Spectral AI, Inc., DeepView leverages predictive diagnostics technology to provide clinicians with an objective and immediate assessment of a wound's healing potential. This AI-powered device is designed to help healthcare professionals make informed treatment decisions by evaluating numerous factors that influence wound recovery. The goal of DeepView is to improve the quality of wound care treatments, reduce recovery times, and minimize the risk of complications, thereby enhancing the overall patient care experience in cases of burns and diabetic foot ulcers.